Following the US FDA’s 21 CFR Part 11 regulation is a critical element for FDA-regulated industries to ensure compliance. In this document we assess the different sections regarding the compliance of the Tetra Data Platform with the requirements for Electronic Records and Electronic Signatures as defined in the guidance document. It helps identify the coverage and responsibility of each of these sections.